| Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers. | |
| | |
MedLine Citation:
|
PMID: 8728349 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Orlistat, a lipase inhibitor, reduces dietary fat absorption, and thus could potentially alter the absorption of some concomitantly administered drugs, such as the nifedipine gastrointestinal therapeutic system (GITS). To assess the effect of orlistat on the bioavailability of nifedipine GITS, a third party-blind, placebo-controlled, randomized, two-way crossover study was performed in 18 healthy volunteers. Each participant received single 60-mg oral doses of nifedipine GITS (Procardia XL; Pfizer Labs, New York, NY) on the fourth day of treatment with 120 mg of orlistat or placebo three times a day for 6 days. The two treatments were separated by a washout period of at least 1 week. Serial blood samples were collected before and at appropriate intervals after each nifedipine dose to determine plasma concentrations of nifedipine. The 90% confidence intervals for the ratio of geometric least-square means for maximum concentration (C(max)) and area under the concentration-time curve (AUCo-t) and for the difference of arithmetic least-square means for time to maximum concentration (t(max)) indicate that the bioavailability of nifedipine was not altered by treatment with orlistat. Therapeutic doses of 120 mg of orlistat three times daily do not significantly alter the bioavailability of a single 60-mg oral dose of nifedipine GITS in healthy volunteers. |
| | |
Authors:
|
A T Melia; T E Mulligan; J Zhi |
Related Documents
:
|
17236889 - Efficacy and safety of extended release metoprolol succinate in hypertensive children 6... 3886399 - Effects of bay l 5240, a fixed combination of low dose nifedipine and acebutolol on hyp... 8520809 - Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive pat... 7720759 - Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and... 10202659 - Lower dosages of phentermine-fenfluramine given in the afternoon: five cases with signi... 3410219 - Effect of nifedipine on sphincter of oddi motor activity: studies in healthy volunteers... 8816939 - Lack of micronucleus induction by 'sobatum' in bone marrow erythrocytes of swiss mice. 1365649 - Effect of acute and chronic benzodiazepines on plasma gaba in anxious patients and cont... 9649989 - Addition of droperidol to morphine administered by the patient-controlled analgesia met... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of clinical pharmacology Volume: 36 ISSN: 0091-2700 ISO Abbreviation: J Clin Pharmacol Publication Date: 1996 Apr |
Date Detail:
|
Created Date: 1996-09-30 Completed Date: 1996-09-30 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0366372 Medline TA: J Clin Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 352-5 Citation Subset: IM |
Affiliation:
|
Hoffmann-La Roche, Inc., Nutley, New Jersey 07110-1199, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adult Analysis of Variance Biological Availability Calcium Channel Blockers / administration & dosage, blood, pharmacokinetics* Cross-Over Studies Delayed-Action Preparations Drug Interactions Enzyme Inhibitors / pharmacology* Female Humans Hypertension / metabolism Lactones / pharmacology* Male Middle Aged Nifedipine / administration & dosage, blood, pharmacokinetics* |
| Chemical | |
Reg. No./Substance:
|
0/Calcium Channel Blockers; 0/Delayed-Action Preparations; 0/Enzyme Inhibitors; 0/Lactones; 21829-25-4/Nifedipine; 96829-58-2/orlistat |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in po...
Next Document: Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyri...